Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03461783 · ClinicalTrials.gov registry record · NA
Activated Carbon Interphase Effect on Biofilm and Total Bacterial Load
A NA study of Wound Infection, sponsored by Brock Liden, DPM.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
- 2
- Study locations
NCT03461783 is a NA study of Wound Infection that has completed, run by Brock Liden, DPM. The registered enrollment target is 21 participants, below the 376-participant average among 10 other Wound Infection trials with a reported enrollment target (94% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT03461783, a NA study of Wound Infection, has completed, sponsored by Brock Liden, DPM.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this randomized, prospective study is to evaluate how this activated carbon dressing affects the total bacterial load and biofilm in a wound bed in wounds of the lower extremity and foot. We anticipate that the use of Zorflex® Activated Carbon Cloth dressing will maintain the bacterial burden in the wound bed below the level of critical colonization, with potential secondary benefits of pain reduction, decrease in inflammation, and control of odor. Wound bed healing progression/acceleration also will be assessed.
Conditions Studied
Interventions
- DEVICE Standard of Care
- DEVICE Zorflex Activated Carbon Dressing
Study Locations (2)
Ohio
- Circleville Foot & Ankle, LLC - Circleville
- Hocking Valley Community Hospital - Logan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2017-06-26 |
| Est. Completion | 2019-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03461783
The ClinicalTrials.gov registry entry for NCT03461783 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 376-participant average among 10 other Wound Infection trials with a reported enrollment target (94% lower). The listed sponsor is Brock Liden, DPM, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Wound Infection appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care is the first listed.
NCT03461783 reports 2 study locations spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT03461783 about?
NCT03461783 is a clinical study titled "Activated Carbon Interphase Effect on Biofilm and Total Bacterial Load". The purpose of this randomized, prospective study is to evaluate how this activated carbon dressing affects the total bacterial load and biofilm in a wound bed in wounds of the lower extremity and foot. We anticipate that the use of Zorflex® Activated Carbon Cloth dressing will maintain the bacteria...
What is the current status of trial NCT03461783?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2017-06-26. Estimated completion is 2019-02-01.
What conditions does trial NCT03461783 study?
This clinical trial studies the following conditions: Wound Infection.
What interventions are being tested in trial NCT03461783?
The interventions under investigation include: Standard of Care (DEVICE), Zorflex Activated Carbon Dressing (DEVICE).
Who is sponsoring clinical trial NCT03461783?
This trial is sponsored by Brock Liden, DPM, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03461783 being conducted?
This trial has 2 study locations across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Wound Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Randomized Trial of Ostomy Closure Techniques
COMPLETED · NA
-
Randomized Trial to Assess PO Versus IV Antibiotics
COMPLETED · NA
-
Tobramycin Injection to Prevent Infection in Open Fractures
ACTIVE NOT RECRUITING · Phase 3
-
Comparing Outcomes for Prontosan Versus Normal Saline for Negative Pressure Wound Therapy With Instillation
COMPLETED · Phase 4
-
Tissue Penetration of Ceftolozane/Tazobactam in Diabetic Patients With Lower Limb Infections
COMPLETED · Phase 1
-
A Study to Evaluate a Quality Improvement Intervention to Reduce Wound Separation Rates in Obese Gynecologic Oncology Service Patients Undergoing Abdominal Surgery
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.